Role of Milk Fat Globule Membranes in Dairy Foods: Health Effects in Humans

NCT01767077 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2013-09-25

No results posted yet for this study

Summary

Investigate the effects of milk fat with or without milk fat globule membranes (MFGM) on blood lipid profile, vascular function, insulin sensitivity, inflammation and gene expression. Overweight subjects will be randomized to one of 2 groups with different types of dairy products: 1)butter oil; 2) cream (milk fat with MFGM).

Conditions

Interventions

DIETARY_SUPPLEMENT

Butter oil

Daily intake of 40 g butter oil

DIETARY_SUPPLEMENT

Cream

Daily intake of 100 g cream (40%)

Sponsors & Collaborators

  • Lund University

    collaborator OTHER
  • LRF Mjölk, Sweden

    collaborator UNKNOWN
  • Arla Foods

    collaborator INDUSTRY
  • Skånemejerier, Sweden

    collaborator UNKNOWN
  • Semper AB, Sweden

    collaborator UNKNOWN
  • The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)

    collaborator OTHER_GOV
  • Swedish Nutrition Foundation SNF

    collaborator UNKNOWN
  • Vinnova

    collaborator OTHER_GOV
  • The Swedish Farmers' Foundation for Agricultural Research

    collaborator UNKNOWN
  • Livsmedelsföretagen, Sweden

    collaborator UNKNOWN
  • Svensk Dagligvaruhandel, Sweden

    collaborator UNKNOWN
  • Uppsala University

    lead OTHER

Principal Investigators

  • Ulf Risérus, Assoc prof · Uppsala University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01767077 on ClinicalTrials.gov